Dynamic nature of hepatic differentiation in lung adenocarcinoma
Histopathology · 2025
DOI: 10.1111/his.15517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2025. Verfasst von Chihiro Takemura und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Adenocarcinoma, Hepatocytes, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Aims
Hepatic differentiation in lung adenocarcinomas, including hepatoid adenocarcinomas, is rare. We encountered a case of lung adenocarcinoma with distinct cytoplasmic TTF‐1 expression, which is characteristic of neoplastic and non‐neoplastic hepatocytes, and confirmed positivity for hepatic markers, including hepatocyte paraffin 1 (HepPar1) and glypican‐3. This prompted a retrospective analysis of hepatic differentiation in lung adenocarcinoma. Methods and Results Among 123 surgically resected lung tumours, 1 adenocarcinoma (0.1%) showed positivity for HepPar1, hepatocyte nuclear factor 4‐alpha and cytoplasmic TTF‐1, with heterogeneous expression confined to part of the tumour. This heterogeneity led us to investigate expressional variations in hepatic differentiation during the clinical course. In an analysis of 992 patients with at least two specimens collected during treatment, hepatic differentiation, identified via HepPar1 expression, was present in at least one specimen in 8 patients, with cytoplasmic TTF‐1 expression used as a reference. Notably, in 7 of 8 patients, hepatic differentiation emerged or expanded with disease progression, suggesting its dynamic nature and potential association with disease progression.
Conclusions
The observed variability in hepatic marker expression over the clinical course suggests that hepatic differentiation may be a dynamic process influenced by treatment or disease progression, rather than a static characteristic of a distinct tumour entity. In routine practice, hepatic differentiation is tracked using cytoplasmic TTF‐1 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan.
- Department of Comprehensive Oncology, Nagasaki University Graduate School of Biomedical Sciences, Tokyo, Japan.
- Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Respiratory Oncology, National Cancer Center Hospital, Tokyo, Japan.
ORCID-Profile: Chihiro Takemura, Satsuki Kishikawa, Jumpei Kashima, Hiroshi Igaki, Masahiro Kusumoto, Yuichiro Ohe, Shun-Ichi Watanabe, Yasushi Yatabe
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Takemura, C., Kishikawa, S., Kashima, J., Igaki, H., Kusumoto, M., Ohe, Y., Watanabe, S. I., & Yatabe, Y. (2025). Dynamic nature of hepatic differentiation in lung adenocarcinoma. Histopathology. https://doi.org/10.1111/his.15517
Vancouver
Takemura C, Kishikawa S, Kashima J, Igaki H, Kusumoto M, Ohe Y, et al. Dynamic nature of hepatic differentiation in lung adenocarcinoma. Histopathology. 2025. doi:10.1111/his.15517
BibTeX
@article{Takemura2025,
author = {Takemura, Chihiro and Kishikawa, Satsuki and Kashima, Jumpei and Igaki, Hiroshi and Kusumoto, Masahiro and Ohe, Yuichiro and Watanabe, Shun-Ichi and Yatabe, Yasushi},
title = {Dynamic nature of hepatic differentiation in lung adenocarcinoma},
journal = {Histopathology},
year = {2025},
doi = {10.1111/his.15517}
}
EUVIMED